The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.
In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient market’s manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.
The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.
The report segments the global active pharmaceutical ingredient market as
Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis
- Biotech API
- Synthetic Chemical API
Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis
- Contract Manufacturing
- In-House API Manufacturing
Active Pharmaceutical Ingredient Market: Type of API Segment Analysis
- Synthetic API
- Biological API
Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis
- Branded Drugs
- Generic Drugs
- OTC Drugs
Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis